Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087826 · ClinicalTrials.gov registry record · NA
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
A NA study of Type 2 Diabetes and Metabolism, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 1,017
- Enrollment target
- 1
- Study location
NCT02087826 is a NA study of Type 2 Diabetes and Metabolism that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 1,017 participants, roughly in line with the 1,099-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT02087826, a NA study of Type 2 Diabetes and Metabolism, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,017 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to examine whether specific genes (e.g. SLC16A11) affect how human beings respond to food and a medication that is commonly used to treat type 2 diabetes. The food the investigators will be studying is specially prepared to contain protein, carbohydrate, and fat. The drug the investigators are studying is metformin. The investigators hypothesize that physiological responses to the meal and to the medication will differ between carriers and non-carriers of genes associated with type 2 diabetes.
Conditions Studied
Interventions
- DRUG Metformin
- OTHER Mixed Meal Tolerance Test
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,017 participants |
| Start Date | 2014-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02087826
The ClinicalTrials.gov registry entry for NCT02087826 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,017 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,099-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Metformin is the first listed.
NCT02087826 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02087826 about?
NCT02087826 is a clinical study titled "Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS". The purpose of this research study is to examine whether specific genes (e.g. SLC16A11) affect how human beings respond to food and a medication that is commonly used to treat type 2 diabetes. The food the investigators will be studying is specially prepared to contain protein, carbohydrate, and fat...
What is the current status of trial NCT02087826?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,017 participants. The study started on 2014-04. Estimated completion is 2026-12.
What conditions does trial NCT02087826 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Metabolism, Genetics.
What interventions are being tested in trial NCT02087826?
The interventions under investigation include: Metformin (DRUG), Mixed Meal Tolerance Test (OTHER).
Who is sponsoring clinical trial NCT02087826?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02087826 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.